OMB logged the FDA's interim access proposal. Leerink estimated a $2.2B telehealth peptide market, and Hims says it is already testing peptide APIs.
Recap by typeshit. Full story at TradingView.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
35:20
Manuel Enrique runs a second 50 day stretch on peptides and reports how it went. These are personal claims, not established results.
Welltica+ reports the drug could prevent about 70% of the muscle loss people usually see while taking Ozempic and similar drugs.
Loading…